CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (9) , 445-451
- https://doi.org/10.1016/j.molmed.2004.07.003
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Recycling the Cell CycleCell, 2004
- Erratic expression of DNA polymerases by β‐amyloid causes neuronal deathThe FASEB Journal, 2002
- Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP‐treated monkeys: Feasibility relevant to multiple‐target grafting as a therapy for Parkinson's diseaseJournal of Comparative Neurology, 2001
- Structure and Regulation of the CDK5-p25nck5a ComplexPublished by Elsevier ,2001
- Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseasesNeurobiology of Aging, 2000
- Induction and Modulation of Cerebellar Granule Neuron Death by E2F-1Journal of Biological Chemistry, 2000
- E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3Journal of Biological Chemistry, 2000
- Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal deathFEBS Letters, 1999
- Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal DeathJournal of Biological Chemistry, 1999
- Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic miceNeuron, 1992